风疹诊断测试市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

风疹诊断测试市场按测试技术(乳胶凝集、酶免疫测定 (EIA)、放射免疫测定 (RIA)、荧光免疫测定 (FIA) 和其他测试技术)、应用和地理进行细分。

市场快照

Rubella Diagnostic Testing Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.5 %
Rubella Diagnostic Testing Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

风疹诊断检测市场增长的主要因素包括政府遏制风疹病毒的举措、风疹发病率的增加以及先进的即时诊断技术的引入,这些都有望推动整体增长。预测期内的市场。

全世界风疹的发病率有所增加。风疹是一种急性、传染性病毒感染,可导致儿童和成人出现轻度发烧和皮疹。怀孕期间的感染,尤其是在孕早期感染,可导致流产、死产、胎儿死亡或先天性畸形婴儿。根据美国疾病控制与预防中心 (CDC) 公布的数据,风疹是一个全球性的健康问题,全球每年报告的先天性风疹综合征 (CRS) 病例超过 100,000 例。在怀孕的前三个月感染风疹的妇女有高达 90% 的机会生下患有先天性风疹综合征的婴儿。

另一方面,根据全球疫苗行动计划 (GVAP) 评估报告,风疹控制滞后,有 42 个国家尚未引入疫苗。

报告范围

根据报告的范围,风疹诊断检测是指检测风疹病毒。这些测试是为孕妇规定的,也可能对出生有先天缺陷的婴儿进行。风疹可以借助各种诊断测试进行检测,例如乳胶凝集法、酶免疫测定法、放射免疫测定法 (RIA) 和荧光免疫测定法 (FIA) 等。风疹诊断市场按测试技术、应用和地理划分。

Testing Technique
Latex Agglutination
Enzyme Immunoassay (EIA)
Radioimmunoassay (RIA)
Fluorescent Immunoassay (FIA)
Other Testing Techniques
Application
Hospitals
Laboratories
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

检测技术下的酶免疫分析领域占全球市场份额最大

  • 血清中风疹特异性免疫球蛋白M(IgM)的检测是风疹实验室快速诊断的标准检测。 
  • IgM 检测是使用商业酶免疫测定 (EIA) 试剂盒最常用的检测技术。血液测试检测免疫系统产生的用于杀死风疹病毒的抗体,这些抗体会在血液中保留多年。 
  • 由于风疹的发病率不断上升,预计该细分市场将占据最大的市场份额。
Rubella Diagnostic Testing Market Share

亚太地区占全球市场增长率最高

按地域划分,亚太地区风疹诊断检测市场的增长速度最快,预计在预测期内将呈现类似趋势,且不会出现显着波动。 

由于存在更大的未开发机会、一些国家缺乏认识以及政府为遏制疾病发病率而采取的举措,亚太地区的市场份额最高。 

根据 2017 年全球疫苗行动计划 (GVAP) 评估报告,42 个国家尚未引入该疫苗,非洲和东地中海两个地区尚未设定风疹消除或控制目标。预计这些地区将面临风疹的高发,这可能会进一步推动市场的增长。

Rubella Diagnostic Testing Market Growth

竞争格局

所研究的市场由少数主要参与者主导,市场上的大多数参与者都专注于开发新技术以获得最大的市场份额。主要市场参与者的存在,例如 Abbott Laboratories、Bio Rad Laboratories Inc.、BioMerieux SA、Siemens AG 和 Thermo Fisher Scientific Inc.,正在增加市场的整体竞争。

主要玩家

  1. Abbott

  2. Bio Rad Laboratories Inc.

  3. bioMérieux SA

  4. Siemens Healthcare GmbH

  5. Thermo Fisher Scientific Inc.

Abbott Laboratories, Bio Rad Laboratories Inc., BioMerieux SA, Siemens AG, and Thermo Fisher Scientific Inc

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Government Initiatives to Curb Rubella Virus

      2. 4.2.2 Increasing Incidences of Rubella

      3. 4.2.3 Introduction of Advance Point-of-care Diagnostic Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness among Developing Regions

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Testing Technique

      1. 5.1.1 Latex Agglutination

      2. 5.1.2 Enzyme Immunoassay (EIA)

      3. 5.1.3 Radioimmunoassay (RIA)

      4. 5.1.4 Fluorescent Immunoassay (FIA)

      5. 5.1.5 Other Testing Techniques

    2. 5.2 Application

      1. 5.2.1 Hospitals

      2. 5.2.2 Laboratories

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott

      2. 6.1.2 Beckman Coulter Inc.

      3. 6.1.3 Bio Rad Laboratories Inc.

      4. 6.1.4 Biokit SA

      5. 6.1.5 bioMérieux SA

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 Ortho Clinical Diagnostics

      8. 6.1.8 Siemens Healthcare GmbH

      9. 6.1.9 Thermo Fisher Scientific

      10. 6.1.10 ZEUS Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Rubella Diagnostic Testing Market market is studied from 2018 - 2026.

The Rubella Diagnostic Testing Market is growing at a CAGR of 4.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott, Bio Rad Laboratories Inc., bioMérieux SA, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc. are the major companies operating in Rubella Diagnostic Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!